Global Asset Managers Expand Holdings in South Korean Pharma and Biotech
Major institutional asset managers are steadily increasing their equity stakes in South Korean pharmaceutical and biotechnology companies, drawn by...
Search results for "pharma and biotech"
South Korea Overhauls Pharma and Biotech Disclosure Rules Following Samchundang Controversy
South Korean financial authorities are overhauling disclosure regulations across the pharmaceutical and biotechnology sectors to curb exaggerated...
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%
Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major...
117 Workplace Accidents Recognized at 25 Major Korean Pharma and Biotech Firms Over Five Years
A review of 25 major South Korean pharmaceutical and biotechnology companies revealed 117 recognized industrial...
South Korean Biotechs Race to Conquer the Untapped Global MASH Market
Fat accumulation in the liver can trigger severe inflammation even in individuals who completely abstain from alcohol.
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour
Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
GC Pharma Partners with France’s Osivax to Develop Next-Generation Combination Flu Vaccine
GC Pharma has entered into a strategic partnership with French biotech firm Osivax to develop and commercialize a...
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51
Celltrion announced on August 24 that it has submitted a marketing authorization application to South Korea’s Ministry...
KHIDI Accelerates Biohealth R&D Support with Agency-Wide AI Transformation
Staff supporting biohealth research and development (R&D) spend substantial time navigating and analyzing massive...
Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4
Biotechnology firm Alteogen has signed an exclusive technology-transfer agreement worth up to $365 million...